Pss40 - Cost-Effectiveness of Ocriplasmin for the Treatment of Vitreomacular Traction, Including When Associated With Macular Hole: A Belgian Perspective
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2540
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV